Dr. Tulpule is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Ste 8302E
Los Angeles, CA 90089Phone+1 323-865-3000Fax+1 323-864-0060
Education & Training
Osmania Medical College NTR UHSClass of 1978
Certifications & Licensure
CA State Medical License 1988 - 2026
MD State Medical License 1987 - 1991
Clinical Trials
- Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas Start of enrollment: 2005 Apr 01
- Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas Start of enrollment: 2003 Jan 10
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma Start of enrollment: 2006 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsPhase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymp...Anil Tulpule, Byron M. Espina, Nancy Berman, Laura H. Buchanan, D. Lynne Smith
Clinical Lymphoma & Myeloma. 2006-07-01 - 7 citationsMultidrug resistance in AIDS-related lymphoma.Anil Tulpule
Current Opinion in Oncology. 2005-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
